Log in to save to my catalogue

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial:...

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8bb7d4dfed634839a0345565b6c71816

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

About this item

Full title

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

Publisher

England: BioMed Central Ltd

Journal title

Cancer imaging, 2020-10, Vol.20 (1), p.72-72, Article 72

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The aim of this study is to investigate the potential impact of prostate magnetic resonance imaging (MRI) -related interreader variability on a population-based randomized prostate cancer screening trial (ProScreen).
From January 2014 to January 2018, 100 men aged 50-63 years with clinical suspicion of prostate cancer (PCa) in Helsinki Universit...

Alternative Titles

Full title

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8bb7d4dfed634839a0345565b6c71816

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8bb7d4dfed634839a0345565b6c71816

Other Identifiers

ISSN

1470-7330,1740-5025

E-ISSN

1470-7330

DOI

10.1186/s40644-020-00351-w

How to access this item